The antibody discovery market refers to the collection of technologies, processes and services used by biotechnology and pharmaceutical companies to identify and generate antibodies proteins produced by the immune system that can specifically bind to biological targets such as disease-associated antigens. This market includes methods such as phage display, hybridoma screening, single-cell technologies, and AI-assisted design to enable faster and more accurate identification of antibody candidates for therapeutic and diagnostic applications such as cancer, autoimmune disorders, and infectious diseases. It connects biology, drug discovery, and computational science, making it the center of modern biology development.